Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Telehealth for People with Chronic Achilles Tendinopathy: PTJ Author Interview With Andrew Post

Mar 28, 2023/Podcast

Editor-in-Chief Alan Jette interviews Andrew Post about his study on the efficacy of physical therapy delivered via telehealth in people with chronic Achilles tendinopathy.

From PTJ: For Carpal Tunnel Diagnosis, Don't Rely on Provocative Tests Alone

May 2, 2023/Review

Echoing a CPG on carpal tunnel syndrome from two APTA academies, authors advocate a combination of diagnostic approaches.

Vision Fulfilled

Jul 1, 2015/Column

A career that was meant to be.

The Good Stuff: Members and the Profession in the Media, March 2021

Mar 17, 2021/Roundup

APTA members and the profession in the media, March 2021 edition.

Protecting the Flame: 10 Tips to Help You Avoid Burnout

Nov 24, 2021/Perspective

If you are experiencing symptoms of burnout, you're not alone.

Student Focus: APTA Academy of Education

Aug 1, 2024/Column

APTA Magazine Contributing Editor Christine Scalora interviews Chalee Engelhard, PT, EdD, MBA, president of APTA Academy of Education.

American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), Patient Self-Report Section

May 22, 2017/Test & Measure

A standardized form for the assessment of shoulder function.

Lower Urinary Tract Symptoms in Men: Management [NICE CG97]

Jun 3, 2015/CPG

This guideline aims to improve the quality of life for men over 18 with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.

Why NSC?

Jul 11, 2017/Perspective

For those of you who don't know about NSC, let me share my enriching NSC experience with you.

Harris Infant Neuromotor Test (HINT)

Jul 12, 2021/Test & Measure

The Harris Infant Neuromotor Test (HINT) is a screening tool designed to identify neuromotor or cognitive/behavioral concerns in infants who are healthy or at high risk between the ages of 3 and 12 months.